Single-Center Experience with Venus-P Self-expanding Pulmonary Valve: Insights on Valve Sizing and Procedural Techniques
Pediatric Cardiology · 2026
DOI: 10.1007/s00246-025-03841-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Sok-Leng Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Cardiology, Leeds Teaching Hospitals Trust, Leeds, UK. soklengkang@nhs.net. Hauptthemen laut MEDLINE: Pulmonary Valve, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Cardiac Catheterization. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We share a single-center experience of transcatheter pulmonary valve replacement (PVR) with the Venus-P valve, discussing procedural insights, considerations for valve sizing in relation to valve expansion and geometry, and associated outcomes. Retrospective review of 42 consecutive cases from January 2017 to March 2024. The median age and weight of the cohort were 39.6 (27.3, 58.6) years and 69.8 (59.8, 85.3) kg and the Venus-P valve was successfully implanted in 98%. Severe adverse events included valve migration requiring surgical explant and PVR ( n = 1), sustained ventricular arrhythmia ( n = 1), and endocarditis ( n = 1). At mean follow-up of 20.3 ± 19.6 months, there was no deterioration in valve performance and statistically significant improvement in NYHA class, right ventricular volumes, biventricular stroke volume, and LV ejection fraction. Cinefluoroscopic measurements of the deployed valves showed highest expansion and lowest eccentricity at valve coaptation level and greater frame deformation at the inflow compared to outflow flare. Supra-annular ( n = 9) implant showed a higher expansion of the straight valve section compared to transannular ( n = 32) deployment, related to lesser degree of valve oversizing and tissue characteristics at implant site. Transcatheter PVR with the Venus-P valve can be safely performed in a broad range of anatomies with clinical benefit at medium-term follow-up. Valve sizing focused on adequate deformation of inflow and outflow flares at implant location with minimal constrain at the valve portion and supra-annular positioning, may result in a higher degree of valve expansion and circularity. Ongoing follow-up of this cohort will provide important insights into valve longevity and long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric Cardiology, Leeds Teaching Hospitals Trust, Leeds, UK. soklengkang@nhs.net.
- Department of Paediatric Cardiology, John Hopkins University Hospital, Baltimore, USA.
- Department of Paediatric Cardiology, Alder Hey Children's Hospital, Liverpool, UK.
- Department of Paediatric Cardiology, Leeds Teaching Hospitals Trust, Leeds, UK.
Zitieren
APA
Kang, S. L., Thomson, J. D. R., Duong, P., & Bentham, J. R. (2026). Single-Center Experience with Venus-P Self-expanding Pulmonary Valve: Insights on Valve Sizing and Procedural Techniques. Pediatric Cardiology. https://doi.org/10.1007/s00246-025-03841-5
Vancouver
Kang SL, Thomson JDR, Duong P, Bentham JR. Single-Center Experience with Venus-P Self-expanding Pulmonary Valve: Insights on Valve Sizing and Procedural Techniques. Pediatric Cardiology. 2026. doi:10.1007/s00246-025-03841-5
BibTeX
@article{Kang2026,
author = {Kang, Sok-Leng and Thomson, J D R and Duong, Phuoc and Bentham, James R},
title = {Single-Center Experience with Venus-P Self-expanding Pulmonary Valve: Insights on Valve Sizing and Procedural Techniques},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-025-03841-5}
}
EUVIMED